Bank of New York Mellon
OPTR

Bank of New York Mellon’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bank of New York Mellon’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-250,812
Closed -$3.16M – 4318
2013
Q3 		$3.16M Buy
250,812
+9,059
+4% +$120K ﹤0.01% 2538
2013
Q2 		$3.5M Buy
+241,753
New +$3.52M ﹤0.01% 2409

Bank of New York Mellon's OPTR Position: Q4 2013 in Review

Bank of New York Mellon sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 250,812 shares — an estimated $3.16M sold.

Bank of New York Mellon first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $3.5M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Bank of New York Mellon reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Bank of New York Mellon sold 250,812 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $3.16M.
  • Bank of New York Mellon first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Bank of New York Mellon's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $3.5M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Bank of New York Mellon's 13F filing for Q4 2013, filed 12 Feb 2014.